Cargando…
Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
Eccrine porocarcinoma (EPC) is a rare malignancy of the sweat glands. Currently, there is no standard algorithm for its presentations, diagnosis, and management. However, immunotherapy is an emerging option that may be crucial to the treatment of EPC. This report presents a case of a 79-year-old mal...
Autores principales: | Singh, Arminder, Nguyen, Lam, Everest, Stephanie, Vinogradov, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719723/ https://www.ncbi.nlm.nih.gov/pubmed/34987895 http://dx.doi.org/10.7759/cureus.20004 |
Ejemplares similares
-
Eccrine Porocarcinoma of the Chest Wall
por: Kangabam, Boris, et al.
Publicado: (2022) -
Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017) -
The transition between a poroma and a porocarcinoma evidenced by the
dermoscopy
por: Uchiyama, Juliana, et al.
Publicado: (2019) -
Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary
por: Sethi, Ashish, et al.
Publicado: (2021) -
Successful Management of Metastatic Eccrine Porocarcinoma
por: Aaribi, Imane, et al.
Publicado: (2013)